CN105315159B - 一种化合物的拆分方法 - Google Patents
一种化合物的拆分方法 Download PDFInfo
- Publication number
- CN105315159B CN105315159B CN201410415353.8A CN201410415353A CN105315159B CN 105315159 B CN105315159 B CN 105315159B CN 201410415353 A CN201410415353 A CN 201410415353A CN 105315159 B CN105315159 B CN 105315159B
- Authority
- CN
- China
- Prior art keywords
- formula
- rac
- splitting
- compound
- nitroolefin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种化合物的拆分方法。本发明拆分方法,操作简便,无需特别使用具备光学异构的中间体进行反应,就可以简单有效地拆分得到(S)‑3手性化合物,为相关化合物的手性拆分提供了新的选择。
Description
技术领域
本发明涉及一种化合物的拆分方法。
背景技术
手性因素在生物学、化学及其他多领域中都具有极其重要的影响力。随着有机化学和生物化学的发展,化合物的手性特征已开始受到越来越多的重视。众多研究表明,不同的光学异构体可能具有截然不同的生理活性、转运机制、代谢速率和毒性,在吸收、分布和***方面也不尽相同。
手性拆分(Chiral resolution),亦称光学拆分(Optical resolution)或外消旋体拆分,为立体化学上,用以分离外消旋化合物成为两个不同的镜像异构物的方法。通常使用的拆分方法有结晶拆分法、化学拆分法、酶解法和柱色谱分离法等,其中,化学拆分法常使用一个纯的光活性异构体参加反应,形成非对映体,再将非对映体逆向反应脱去纯的光活性异构体即可。然而并非所有化合物都能够找到适合的光活性异构体参与反应,若能够找到一种不使用特定光活性异构体就能够拆分化合物的方法,将会为手性拆分方法提供新的思路和选择。
发明内容
本发明的目的在于提供一种化合物的手性拆分方法。
具体地,本发明提供了如下所示(S)-3化合物的拆分方法,反应途径如下:
Rac-3为的外消旋体;
R1选自苯环、取代苯环或五元或六元杂环,R2选自C1-C4烷基,R3选自H或C1-C4烷基。
进一步地,所述取代苯基的取代基选自卤素或硝基,取代基数量为1~3个。
更进一步地,所述卤素选自F、Cl或Br。
更进一步地,取代基数量为1个或2个。
进一步地,所述C1-C4烷基选自甲基或乙基。
进一步地,具体操作步骤如下:
取Rac-3加入醛4,二苯基脯氨醇硅醚IIa和冰醋酸,反应在室温下进行,用TLC监测至反应结束,浓缩并硅胶柱层析(PE/EA=10:1)先后分离得到MBH产物(S)-3和手性四氢吡喃醇产物5。
进一步地,Rac-3的制备方法为:
其中,Rac-3制备方法的具体操作步骤如下:
硝基烯烃1和羰基化合物2在DMAP存在下,以MeCN做溶剂,室温搅拌得到MBH加成产物rac-3。
MBH即贝里斯-希尔曼反应。
更进一步地,式1所示硝基烯烃:式2所示羰基化合物:DMAP:式4所示醛:催化剂:冰醋酸=0.5-1.0mmol:1.0mmol:0.05-0.2mmol:1.0-2.0mmol:0.1-0.3mmol:0.1-0.2mmol。
优选地,式1所示硝基烯烃:式2所示羰基化合物:DMAP:式4所示醛:催化剂:冰醋酸=0.5mmol:1.0mmol:0.05mmol:1.0mmol:0.1mmol:0.1mmol。
本发明拆分方法,操作简便,无需特别使用具备光学异构的中间体进行反应,就可以简单有效地拆分得到(S)-3手性化合物,为相关化合物的手性拆分提供了新的选择。
以下通过具体实施方式对本发明作进一步的详细描述,但并不限制本发明,本领域技术人员可以根据本发明作出各种改变和变形,只要不脱离本发明的精神,均应属于本发明所附权利要求的范围。
具体实施方式
实施例1 本发明拆分方法
硝基烯烃1(0.5mmol)和具有活性的羰基化合物2(1.0mmol)在DMAP(6.1mg,0.05mmol)的存在下,以MeCN做溶剂,室温搅拌30min得到MBH加成产物rac-3。接着一锅法加入醛4(1.0mmol),二苯基脯氨醇硅醚IIa(32.5mg,0.1mmol)和冰醋酸(6.0mg,0.1mmol)。反应在室温下进行,用TLC监测反应进程。浓缩并硅胶柱层析(PE/EA=10:1)先后分离得到MBH产物(S)-3和手性四氢吡喃醇产物5。
拆分的各具体化合物如下:
(d,J=7.6Hz,2H),5.35(d,J=4.8Hz,1H),5.18(dd,J=9.6Hz,J=6.0Hz,1H),5.07(d,J=5.6Hz,1H),4.26-4.20(m,2H),4.03(br s,1H),3.16(t,J=11.6Hz,1H),1.97-1.94(m,1H),1.24(t,J=7.2Hz,3H),0.86(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.95,137.63,129.11,128.07,128.00,98.15,89.72,69.35,62.29,48.19,39.32,15.50,13.85ppm;ESI HRMS:计算值C15H19NO6+Na 332.1110,实测值332.1112.
[α]D 20+108.4(c=0.21in CH2Cl2).
1H),7.31-7.19(m,3H),5.30(br s,2H),5.10(d,J=4.8Hz,1H),4.34(br s,1H),4.30-4.23(m,2H),2.12-2.05(m,1H),1.25(t,J=6.8Hz,3H),0.88(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.89,130.43,130.26,129.13,128.32,127.67,127.40,98.39,95.33,83.64,69.98,68.89,62.38,15.08,13.88ppm;ESI HRMS:calcd.For C15H18ClNO6+Na366.0720,实测值366.0716.
(S)-3b:谱图数据与消旋产物3b一致。收率:39%(55.7mg).高效液相CelluCoat柱测定ee值98%(5%2-propanol/n-hexane,1mL/min),UV 220nm,tminor=13.24min,tmajor=14.23min.旋光:[α]D 20+86.2(c=0.11in CH2Cl2).
7.20(s,1H),7.10-7.08(m,1H),5.34(dd,J=7.6Hz,J=4.4Hz,1H),5.13(dd,J=10.4Hz,J=6.0Hz,1H),5.04(d,J=5.6Hz,1H),4.28-4.21(m,2H),3.46(d,J=4.0Hz,1H),3.21-3.15(m,1H),1.95-1.85(m,1H),1.26(t,J=7.2Hz,3H),0.87(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.64,139.71,135.02,130.40,128.41,128.09,126.32,97.82,88.98,69.60,62.34,47.65,39.49,15.36,13.87ppm;高分辨质谱ESI HRMS:计算值C15H18ClNO6+Na 366.0720,实测值366.0723.
2-propanol/n-hexane,1mL/min),UV 220nm,tminor=10.13min,tmajor=19.33min.旋光:[α]D 20+97.6(c=0.15in CH2Cl2).
δ=7.35(d,J=8.0Hz,2H),7.14(d,J=7.6Hz,2H),5.33(d,J=6.8Hz,1H),5.13(dd,J=10.0Hz,J=6.0Hz,1H),5.06(d,J=5.6Hz,1H),4.26-4.20(m,2H),4.06(br s,1H),3.15(t,J=11.2Hz,1H),1.95-1.89(m,1H),1.24(t,J=7.2Hz,3H),0.85(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=166.80,135.12,132.96,128.34,128.31,96.94,88.37,68.25,61.35,46.58,38.26,14.41,12.82ppm;高分辨质谱ESI HRMS:计算值C15H18ClNO6+Na366.0720,实测值366.0723.
(S)-3d:谱图数据与消旋产物3d一致.收率:38%(54.3mg).高效液相AD-H柱测定ee值98%(10%2-propanol/n-hexane,1mL/min),UV 220nm,tminor=16.01min,tmajor=30.78min.旋光:[α]D 20+82.4(c=0.12in CH2Cl2).
CDCl3):δ=7.44(s,1H),7.31-7.21(m,2H),5.28(br s,2H),5.07(d,J=4.4Hz,1H),4.32-4.23(m,2H),4.09(br s,1H),3.92-3.80(m,1H),2.05(br s,1H),1.25(t,J=7.2Hz,3H),0.87(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.68,134.37,130.25,130.08,128.07,127.74,127.67,98.19,95.18,83.25,69.86,69.01,62.44,14.99,13.88ppm;高分辨质谱ESI HRMS:calcd.For C15H17Cl2NO6+Na 400.0331,实测值400.0328.
旋光:[α]D 20+76.9(c=0.21in CH2Cl2).
CDCl3):δ=7.45(d,J=8.4Hz,1H),7.37(s,1H),7.24-7.23(m,1H),7.14(d,J=7.6Hz,1H),5.32(d,J=7.2Hz,1H),5.15(dd,J=9.6Hz,J=5.6Hz,1H),5.07(d,J=5.6Hz,1H),4.44(brs,1H),4.25-4.20(m,2H),3.14(t,J=11.2Hz,1H),1.97-1.89(m,1H),1.24(t,J=7.2Hz,3H),0.87(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=166.91,139.13,130.29,129.95,129.64,125.83,122.14,96.99,88.27,68.11,61.41,46.89,38.22,14.52,12.82ppm;高分辨质谱ESI HRMS:计算值C15H18BrNO6+Na 410.0215,实测值410.0211.
(S)-3f:谱图数据与消旋产物3f一致。收率:41%(67.7mg).高效液相AD-H柱测定ee值90%(15%2-propanol/n-hexane,1mL/min),UV 220nm,tminor=9.80min,tmajor=18.88min.旋光:[α]D 20+65.8(c=0.16in CH2Cl2).
CDCl3):δ=7.50(d,J=7.6Hz,2H),7.08(d,J=7.6Hz,2H),5.33(d,J=4.0Hz,1H),5.12(dd,J=9.6Hz,J=6.0Hz,1H),5.05(d,J=5.2Hz,1H),4.25-4.21(m,2H),4.08(br s,1H),3.14(t,J=11.2Hz,1H),1.95-1.88(m,1H),1.24(t,J=7.2Hz,3H),0.85(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=166.80,135.66,131.29,128.65,121.05,96.91,88.26,68.27,61.36,46.65,38.23,14.40,12.82ppm;高分辨质谱ESI HRMS:计算值C15H18BrNO6+Na 410.0215,实测值410.0217.
min,tmajor=32.45min.旋光:[α]D 20+87.2(c=0.16in CH2Cl2).
CDCl3):δ=7.19-7.16(m,2H),7.08-7.04(m,2H),5.35-5.33(m,1H),5.13(dd,J=9.6Hz,J=6.0Hz,1H),5.06(d,J=5.6Hz,1H),4.29-4.17(m,3H),3.15(t,J=11.2Hz,1H),1.96-1.90(m,1H),1.24(t,J=7.2Hz,3H),0.85(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.93,162.36(d,JCF=246Hz),133.38(d,JCF=3Hz),129.59(d,JCF=8Hz),116.14(d,JCF=21Hz),98.08,89.76,69.19,62.38,47.57,39.35,15.49,13.84ppm;高分辨质谱ESI HRMS:计算值C15H18FNO6+Na 350.1016,实测值350.1011.
(S)-3h:谱图数据与消旋产物3h一致.收率:36%(48.5mg).高效液相AD-H柱测定ee值99%(15%2-propanol/n-hexane,1mL/min),UV 220nm,tminor=12.73min,tmajor=24.56min.旋光:[α]D 20+75.4(c=0.20in CH2Cl2).
7.67(t,J=7.6Hz,1H),7.51-7.47(m,2H),5.35-5.21(m,2H),5.12(d,J=5.2Hz,1H),4.32-4.18(m,3H),4.03(br s,1H),2.08(br s,1H),1.25(t,J=7.2Hz,3H),0.85(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.62,133.51,133.05,128.91,128.08,125.19,124.96,97.91,95.17,88.35,83.98,69.70,62.52,13.85,13.43ppm;高分辨质谱ESI HRMS:计算值C15H18N2O8+H355.1141,实测值355.1145.
tmajor=34.45min.旋光:[α]D 20+91.6(c=0.16in CH2Cl2).
CDCl3):δ=8.25(d,J=8.4Hz,2H),7.42(d,J=8.4Hz,2H),5.35(dd,J=6.8Hz,J=4.4Hz,1H),5.18(dd,J=10.0Hz,J=6.0Hz,1H),5.10(d,J=5.6Hz,1H),4.31-4.19(m,2H),3.80(d,J=3.6Hz,1H),3.34(t,J=11.2Hz,1H),2.01-1.95(m,1H),1.26(t,J=7.2Hz,3H),0.86(d,J=6.4Hz,3H)ppm;碳谱13C NMR(100MHz,CDCl3):δ=167.58,147.73,145.19,129.08,124.39,97.64,88.44,69.45,62.51,47.80,39.45,15.31,13.86ppm;高分辨质谱ESI HRMS:计算值C15H18N2O8+Na 377.0961,实测值377.0958.
min,tmajor=24.45min.旋光:[α]D 20+65.8(c=0.22in CH2Cl2).
Claims (4)
1.如下所示(S)-3化合物的拆分方法,其特征在于:反应途径如下:
Rac-3为的外消旋体;
R1选自苯环、取代苯环或五元或六元杂环,R2选自C1-C4烷基,R3选自H或C1-C4烷基;
其中,所述取代苯基的取代基选自卤素或硝基;所述卤素选自F、Cl或Br;取代基数量为1个或2个;
具体操作步骤如下:
取Rac-3加入醛4,二苯基脯氨醇硅醚和冰醋酸,反应在室温下进行,用TLC监测至反应结束,浓缩并经过硅胶柱层析,石油醚/乙酸乙酯=10:1洗脱分离得到MBH产物(S)-3和手性四氢吡喃醇产物5;
Rac-3的制备方法为:
硝基烯烃1和羰基化合物2在DMAP存在下,以MeCN做溶剂,室温搅拌得到MBH加成产物Rac-3。
2.根据权利要求1所述的拆分方法,其特征在于:所述C1-C4烷基选自甲基或乙基。
3.根据权利要求1所述的拆分方法,其特征在于:式1所示硝基烯烃:式2所示羰基化合物:DMAP:式4所示醛:二苯基脯氨醇硅醚:冰醋酸=0.5-1.0mmol:1.0mmol:0.05-0.2mmol:1.0-2.0mmol:0.1-0.3mmol:0.1-0.2mmol。
4.根据权利要求3所述的拆分方法,其特征在于:式1所示硝基烯烃:式2所示羰基化合物:DMAP:式4所示醛:二苯基脯氨醇硅醚:冰醋酸=0.5mmol:1.0mmol:0.05mmol:1.0mmol:0.1mmol:0.1mmol。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410415353.8A CN105315159B (zh) | 2014-06-26 | 2014-08-21 | 一种化合物的拆分方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410298812 | 2014-06-26 | ||
CN2014102988129 | 2014-06-26 | ||
CN201410415353.8A CN105315159B (zh) | 2014-06-26 | 2014-08-21 | 一种化合物的拆分方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105315159A CN105315159A (zh) | 2016-02-10 |
CN105315159B true CN105315159B (zh) | 2017-12-15 |
Family
ID=55243562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410415353.8A Expired - Fee Related CN105315159B (zh) | 2014-06-26 | 2014-08-21 | 一种化合物的拆分方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105315159B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105315248A (zh) * | 2014-06-26 | 2016-02-10 | 成都中医药大学 | 一种四氢吡喃醇系列手性化合物及其合成方法和用途 |
-
2014
- 2014-08-21 CN CN201410415353.8A patent/CN105315159B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105315248A (zh) * | 2014-06-26 | 2016-02-10 | 成都中医药大学 | 一种四氢吡喃醇系列手性化合物及其合成方法和用途 |
Non-Patent Citations (1)
Title |
---|
Asymmetric One-Pot Four-Component Coupling Reaction: Synthesis of Substituted Tetrahydropyrans Catalyzed by Diphenylprolinol Silyl Ether;Hayato Ishikawa等;《Angew. Chem.》;20110324;第123卷;3858-3863 * |
Also Published As
Publication number | Publication date |
---|---|
CN105315159A (zh) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takiguchi et al. | Total syntheses of (−)-fructigenine A and (−)-5-N-acetylardeemin | |
Qureshi et al. | Introduction of hindered electrophiles via C–H functionalization in a palladium-catalyzed multicomponent domino reaction | |
Viji et al. | Regiodivergent Organocatalytic Reactions | |
Nascimento et al. | Stereoselective synthesis of 8, 9-licarinediols | |
CN103641827A (zh) | 中氮茚衍生物及其合成方法和应用 | |
CN103965093A (zh) | 2-全氟烷基吲哚类化合物及其制备方法和应用 | |
CN105837494A (zh) | 二氟烷基吲哚酮衍生物及其制备方法 | |
CN105315159B (zh) | 一种化合物的拆分方法 | |
CN111072605B (zh) | 一种氟烷基取代的苯并呋喃衍生物或吲哚衍生物的制备方法 | |
Zhang et al. | N-heterocyclic carbene-mediated formal [3+ 3] annulation of isatin-derived α, β-unsaturated acids: Access to functionalized 3, 4′-spirooxindole δ-lactones | |
CN105646327A (zh) | 2-全氟烷基吲哚衍生物及其合成方法 | |
CN112279765B (zh) | 一种手性α-氟代酮化合物的制备方法 | |
CN101891678B (zh) | 4-(n,n-二甲基)氨基吡啶衍生物及其合成方法 | |
CN115010753A (zh) | 一种水相中制备磷酸化偕二氟二烯烃化合物的方法 | |
CN104478799B (zh) | 1,4-二烯丙基异喹啉的制备方法 | |
Xie et al. | Asymmetric synthesis of oxa-spirocyclic indanones with structural complexity via an organocatalytic Michael–Henry–acetalization cascade | |
CN108299369B (zh) | 香豆素-4-磺酸酯衍生物及其制备方法 | |
Konishi et al. | First enantioselective synthesis of exiguamide, a nitrogen-containing spirocyclic sesquiterpene isolated from the marine sponge Geodia exigua | |
CN105384715A (zh) | 一种7-位取代的3-溴-4-苯基香豆素系列化合物制备方法 | |
CN114907246A (zh) | 一种维生素a及其衍生物与其氘代化合物的全合成方法 | |
Kobayashi et al. | Highly stereocontrolled total synthesis of secodolastane diterpenoid isolinearol | |
CN106045842A (zh) | 一种制备洛索洛芬活性代谢物的方法 | |
CN105859557B (zh) | 一种α,β-不饱和羧酸酯化合物的制备方法 | |
CN112299996B (zh) | 一种手性α-氘代酮的合成方法 | |
Alvarez et al. | Enantioselective synthesis of all of the stereoisomers of (E)-13, 14-dihydroxyretinol (DHR) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171215 Termination date: 20200821 |
|
CF01 | Termination of patent right due to non-payment of annual fee |